References
[1] Gaetano C, Stefania D, Giuseppe R, Giovanni C, Nicola M, et al. Frequency of Surgery Among Children Who Have Adenotonsillar Hypertrophy and Improve After Treatment With Nasal Beclomethasone. Pediatrics 2003, 111: 236-238.
[2] Akcay A, Kara CO, Dagdeviren E, and Zencir M. Variation in tonsil size in 4- to 17-year-old schoolchildren. Journal of Otolaryngology 2006, 35: 270-274.
[3] Saedi B, Sadeghi M, Mojtahed M, and Mahboubi H. Diagnostic efficacy of different methods in the assessment of adenoid hypertrophy. American Journal of Otolaryngology 2011, 32: 147-151.
[4] Ras AE, Hamed MH, and Abdelalim AA. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy. Am J Otolaryngol 2020, 41: 102723.
[5] Cheng L, Chen J, Fu Q, He S, Li H, et al. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy, asthma & immunology research 2018, 10: 300-353.
[6] Bousquet J, Hellings PW, Agache I, Amat F, Annesi-Maesano I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol 2019, 143: 864-879.
[7] Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol 2003, 67:1303–1309.
[8] Cho KS, Kim SH, Hong SL, Lee J, Mun SJ, et al. Local Atopy in Childhood Adenotonsillar Hypertrophy. American journal of rhinology & allergy 2018, 32: 160-166.
[9] Muhammed FE, Mahmut Dogru, Ahmet AC, and Merve LN. Adenoid hypertrophy in children with allergic disease and influential factors. International journal of pediatric otorhinolaryngology 2015, 79: 694-697.
[10] Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, et al. Mode of action of intranasal corticosteroids. Journal of Allergy & Clinical Immunology 2001, 108: S16-S25.
[11] Shokouhi F, Jahromi AM, Majidi MR, and Salehi M. Montelukast in Adenoid Hypertrophy: Its Effect on Size and Symptoms. Iranian Journal of Otorhinolaryngology 2015, 27: 443-448.
[12] Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, and Gozal D. Leukotriene Pathways and In Vitro Adenotonsillar Cell Proliferation in Children With Obstructive Sleep Apnea. Chest 2009, 135: 1142-1149.
[13] Paulucci BP, Pereira J, Picciarelli P, Levy D, and Di Francesco RC. Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children. International Forum of Allergy & Rhinology 2016, 6: 1151-1158.
[14] Goldbart AD, Greenberg-Dotan S, and Tal A. Montelukast for Children With Obstructive Sleep Apnea: A Double-blind, Placebo-Controlled Study. Pediatrics 2012, 130: e575-580.